Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Orv Hetil ; 131(24): 1297-300, 1990 Jun 17.
Article in Hungarian | MEDLINE | ID: mdl-2195426

ABSTRACT

Serum concentration of vitamin K1 and activity of vitamin-K-dependent factors II, VII, IX and X were determined before and after vitamin K1 administration in infants. The babies received vitamin K1 intramuscularly or orally. 12 hours after vitamin K1 treatment the mean concentration was increased in the groups receiving vitamin K1 intramusculary or orally, respectively. Serum level of vitamin K1 fell exponentially, the mean half life was about 30 hours in both groups. Activity of vitamin K-dependent clotting factors did not change significantly after intramuscular or oral vitamin K1 administration during the first four-five days of life. It was no direct correlation between the concentration of vitamin K1 and the activity of vitamin-K-dependent clotting factors. This study suggest that oral administration of vitamin K1 is as effective as the intramuscular route.


Subject(s)
Blood Coagulation Factors/analysis , Vitamin K 1/blood , Administration, Oral , Breast Feeding , Clinical Trials as Topic , Erythroblastosis, Fetal/blood , Erythroblastosis, Fetal/prevention & control , Fetal Blood/analysis , Humans , Infant, Newborn , Injections, Intramuscular , Milk, Human , Vitamin K 1/administration & dosage , Vitamin K Deficiency/etiology , Vitamin K Deficiency/prevention & control
3.
Monatsschr Kinderheilkd ; 131(10): 710-3, 1983 Oct.
Article in German | MEDLINE | ID: mdl-6646141

ABSTRACT

The combined application of Tolazoline and Dopamine for the treatment of the persistent fetal circulation syndrome showed that Dopamine prevented the most common side effects of Tolazoline i.e. systemic hypotension and oliguria. The authors emphasize the importance of continuous monitoring of the systemic blood pressure in infants during this treatment.


Subject(s)
Dopamine/therapeutic use , Persistent Fetal Circulation Syndrome/drug therapy , Tolazoline/therapeutic use , Drug Therapy, Combination , Female , Humans , Hypotension/chemically induced , Hypotension/prevention & control , Infant, Newborn , Male , Oliguria/chemically induced , Oliguria/prevention & control , Tolazoline/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...